N Chandrasekaran, Chairman at Tata Sons says it’s an extremely proud moment for the company to be first Indian listed company to hit the coveted $100 billion m-cap figure and it will continue to deliver in terms of growth, profitability & cash flow.
Watch Liberty House Group Chairman Sanjeev Gupta speaks to Siddharth Zarabi on NCLT Process, ABG Shipyard, Amtek Auto and Bhushan Power bids.
In a new twist to the Essar Steel's NCLT saga, JSW Steel has written to Committee of Creditors seeking fresh bidding for Essar Steel. Priyanka Iyer reports.
Nilesh Shah, MD & CEO of Envision Capital says TCS may grow at high single digit or low double digit rate going forward.
IT sector in focus today as TCS touches the hundred billion dollar valuation mark. Market Guru Deven Choksey gave his view on the IT sector and outlines his top investment bets.
NCLT has allowed consideration of Liberty House's bid for Bhushan Power & Steel. Ashutosh Kumar reports.
Orchid Pharma is in RBI's second list of defaulters and is at NCLT currently. The latest update is that the CoC has recently rejected all the three bids for Orchid Pharma. Priyanka Gawande reports.
TCS on Monday was in the news by becoming the first Indian company to breach market capitalisation (m-cap) of $100 billion.
A steady Q4FY18 for HDFC Bank as it has posted record profit of Rs 4799 Cr in Q4FY18. Lalitabh Srivastava, Banking Analyst at Sharekhan joined with his take on the results.
HDFC BANK Q4 REVIEW
PAT at Rs 4799 Cr vs Rs 3990 Cr, up 20.2%
NII at Rs 10,658 Cr vs Rs 9,055 Cr, up 17.7%
Net Interest Margin at 4.3%
Other Income at Rs 4229 Cr vs Rs 3446 Cr, Up 22.7%
Operating Profit at Rs 8835 Cr vs Rs 7279 Cr, up 21.3%
Gets USFDA Approval For Generic Xenazine
Rejects Claims Of Denying An External Audit
SEBI May Seek Forensic Probe Of ICICI Bank Books, Disclosures
Mulling A Forensic Examination Of Financial Statements & Disclosures
Bank's Chairman MK Sharma Conducted A Secret Inquiry 2 Yrs Ago
Found No Wrongdoing By CEO Chanda Kochhar Over Loans To Videocon
Manufacturing Facility At Ghaziabad Inspected By USFDA From April 16-20
Inspection Concluded With Zero Observations
Enters $ 100 Bn Club